{"rows":[{"id":3926,"title":"The Potential of Psilocybin Administration in Terminal Cancer Patients","authors":"Richard Simoneaux","journal":"Oncology Times","publication_date":"2019-06-28","publication_year":2019,"doi":"10.1097/01.cot.0000574916.46844.cf","pubmed_id":null,"openalex_id":"https://openalex.org/W2956046898","source_url":"https://doi.org/10.1097/01.cot.0000574916.46844.cf","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-02 20:42:13","last_checked":"2026-08-09 08:25:49","bibtex":null,"source_record_id":"DOI:10.1097/01.cot.0000574916.46844.cf","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1097/01.cot.0000574916.46844.cf","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1097/01.cot.0000574916.46844.cf","source_url":"https://doi.org/10.1097/01.cot.0000574916.46844.cf","doi":"10.1097/01.cot.0000574916.46844.cf","pmid":"","publication_date":"2019-06-28","importer_version":"2.1.3","text_redistributed":false}},{"id":3861,"title":"Long-Term Analysis of Psilocybin in Cancer Patients With Distress","authors":"Richard Simoneaux","journal":"Oncology Times","publication_date":"2020-03-26","publication_year":2020,"doi":"10.1097/01.cot.0000660232.19098.7f","pubmed_id":null,"openalex_id":"https://openalex.org/W3013419105","source_url":"https://doi.org/10.1097/01.cot.0000660232.19098.7f","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Mystical Experience,Cancer Patients","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-02 20:42:13","last_checked":"2026-08-09 08:25:48","bibtex":null,"source_record_id":"DOI:10.1097/01.cot.0000660232.19098.7f","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1097/01.cot.0000660232.19098.7f","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1097/01.cot.0000660232.19098.7f","source_url":"https://doi.org/10.1097/01.cot.0000660232.19098.7f","doi":"10.1097/01.cot.0000660232.19098.7f","pmid":"","publication_date":"2020-03-26","importer_version":"2.1.3","text_redistributed":false}}],"total":2,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Oncology Times","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}